SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Anteby E, Yagel S, Zacut D, Palti Z, Hochner-Celnikier D. False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen. [Letter]. Lancet. 1992; 340: 433434.
  • 2
    Cohen I, Rosen DJD, Shapira J, et al. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol. 1993; 100: 567570.
  • 3
    Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol. 1993; 81: 660664.
  • 4
    Cohen I, Rosen DJD, Tepper R, et al. Ultrasonographic evaluation of the endometrium with correlation to endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med. 1993; 5: 275280.
  • 5
    Uzieli B, Lewin A, Brufman G, Dorrembus D, Mor-Yosef S. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat. 1993; 26: 101105.
  • 6
    Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. AJR. 1993; 160: 809812.
  • 7
    Cohen I, Rosen DJD, Shapira J, et al. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol. 1994; 52: 185190.
  • 8
    Kedar RP, Bourne TH, Powels TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet. 1994; 343: 13181321.
  • 9
    Ciato S, Cecchini S, Bonardi R, Grozzini G. Ultrasonographic surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet. 1994; 244: 60.
  • 10
    Bo J, Auslender R, Pascal B, Gutterman E, Abramovici H. Diagnostic pitfalls of ultrasonographic screening in women treated with tamoxifen. J Reprod Med. 1994; 39: 674678.
  • 11
    Perrot N, Goyot B, Antonine M. The effect of tamoxifen on the endometrium [Letter]. Ultrasound Obstet Gynecol. 1994; 4: 8386.
  • 12
    Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol. 1994; 170: 447451.
  • 13
    Exacoustos C, Zupi E, Cangi B, Chiartti M, Arduini D, Ramanini C. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound colour flow Doppler, hysteroscopic and histologic study. Ultrasound Obstet Gynecol. 1995; 6: 435442.
  • 14
    Anteby E, Yagel S, Hochner-Celnikier D. Unusual ultrasonographic appearance of the uterus in postmenopausal receiving tamoxifen [Letter]. Am J Obstet Gynecol. 1995; 172: 717.
  • 15
    Anteby E, Yagel S, Weissman A, et al. Sonographic evaluation of the uterus in postmenopausal women receiving tamoxifen: characterisation of mid-uterine abnormalities. Eur J Obstet Gynecol Reprod Biol. 1996; 69: 115119.
  • 16
    Cecchini S, Ciatto S, Bonardi R, et al. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients with tamoxifen treatment. Gynecol Oncol. 1996; 60: 409411.
  • 17
    Tepper R, Beyth Y, Altaras MM, et al. Value of sonohysterography in asymptomatic, postmenopausal tamoxifen-treated patients. Gynecol Oncol. 1997; 64: 386391.
  • 18
    Hann LE, Geiss CS, Bach AM, Tao Y, Baum HJ, Barakat RR. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR. 1997; 168: 657661.
  • 19
    Marconi D, Exacoustos C, Cangi B, et al. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen. J Am Assoc Gynecol Laparosc. 1997; 4: 331339.
  • 20
    Schwartz LB, Snyder J, Horan C, Porges RF, Nachtigall LE, Goldstein SR. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Ultrasound Obstet Gynecol. 1998; 1: 4853.
  • 21
    Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol. 1998; 179: 6270.
  • 22
    Bertelli G, Venturini M, Del Mastro L,et al. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asympotomatic breast cancer patients. Breast Cancer Res Treat. 1998; 47: 4146.
  • 23
    Love CDB, Muir BB, Scrimgeour JB, Leonard RCF, Dillon P, Dixon JM. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol. 1999; 17: 20502054.
  • 24
    Mourits MJE, Van der Zee AGJ, Willemse PHB, et al. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Gynecol Oncol. 1999; 73: 2126.
  • 25
    Tesoro MR, Borgida AF, MacLaurin NA, Asuncion CM. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen. Obstet Gynecol. 1999; 93: 363366.
  • 26
    Nahari K, Tepper R, Beyth Y, Flex D, Figer A, Cohen I. Long-term transvaginal endometrial follow-up in postmenopausal breast cancer patients with tamoxifen treatment. Gynecol Oncol. 1999; 74: 222226.
  • 27
    Gerber B, Krause A, Muller H, et al. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol. 2000; 18: 34643470.
  • 28
    Cohen I, Beyth Y, Azaria R, Flex D, Figer A, Tepper R. Ultrasonographic measurement of endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients. Br J Obstet Gynecol. 2000; 107: 10831087.
  • 29
    Liedman R, Lindhal B, Andolf E, Willen R, Ingvar C, Ranstam J. Discordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and direct biopsy in breast cancer patients treated with tamoxifen. Anticancer Res. 2000; 20: 48894892.
  • 30
    Decensi A, Fontana V, Bruno S, Gustavino C, Gotteschi B, Casta A. Effect of tamoxifen on endometrial proliferation. J Clin Oncol. 1996; 14: 434440.